Konovo

Konovo

Connects healthcare audiences with real-time insights

About Konovo

Simplify's Rating
Why Konovo is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Enterprise Software

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Watertown, Massachusetts

Founded

N/A

Overview

Konovo connects market research agencies and consultancies with healthcare professionals through a platform that provides real-time, tech-enabled data and insights. The platform-as-a-service gives clients direct access to engaged healthcare audiences, helping them quickly anticipate market trends and make informed business decisions. Konovo differentiates itself by focusing specifically on healthcare insights and delivering real-time access to credible professional audiences, tuned to broader business objectives. The company's goal is to be a leading platform in healthcare insights, enabling clients to access credible data and actionable intelligence to drive decision-making.

Simplify Jobs

Simplify's Take

What believers are saying

  • Real-world data capabilities expand with Halliday's Clarivate expertise and India innovation hub scaling.
  • AI governance leadership under Santos positions Konovo ahead of anticipated healthcare AI regulation.
  • Patient-centric insights address underserved rare disease research segment with traditional recruitment gaps.

What critics are saying

  • Rare Patient Voice integration risks 20% panel attrition from mismatched tech and community approaches.
  • Metaforms partnership AI reliability issues cause 30% defective surveys and potential client exodus.
  • Frazier Healthcare Partners divests portfolio amid AI pure-play rebalancing, eliminating funding source.

What makes Konovo unique

  • Merged three healthcare research firms into unified AI-native platform with 2M+ healthcare professional panel.
  • Survey Studio integrates 15 years of healthcare research data with AI-powered questionnaire design.
  • Rare Patient Voice acquisition adds 200,000+ patients across 1,500+ rare and complex diseases.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Hybrid Work Options

Remote Work Options

Wellness Program

Company News

Business Wire
Mar 3rd, 2026
Konovo appoints Jessica Santos as chief compliance and privacy officer

Konovo, a healthcare intelligence company, has appointed Jessica Santos as Chief Compliance and Privacy Officer. Santos brings over 20 years of experience in healthcare compliance, AI governance and data privacy. Santos joins from Oracle Life Sciences, where she served as Global Compliance and Quality Director and Data Protection Officer, overseeing regulation, ethics and compliance across healthcare technologies. She previously held compliance leadership roles at Cerner, Kantar Health and Sermo, and was an associate professor at the University of Cambridge. At Konovo, Santos will integrate compliance, AI governance, legal, data privacy and IT risk into a unified operating model. She will also oversee pharmacovigilance and adverse event monitoring across global markets. Santos holds a PhD from Newcastle University and is a certified AI Governance Professional.

Market Research Society (MRS)
Feb 4th, 2026
Rare Patient Voice joins Konovo

Rare Patient Voice joins Konovo. US - Healthcare intelligence company Konovo has acquired Rare Patient Voice, a panel recruitment company focused on patients and their families, for an undisclosed amount. The acquisition will support Konovo's work on patient-centric insights across therapeutic areas, in particular for rare and complex medical conditions. Rare Patient Voice was launched in 2013 and works across nine countries. Konovo will preserve Rare Patient Voice's approach while supporting it with platform infrastructure. Advertisement Tal Rosenberg, chief executive officer at Konovo, said acquiring Rare Patient Voice would help to bring together "authentic patient perspectives with physician insights" to support researchers. Wes Michael, founder and president of Rare Patient Voice, said: "The combination of RPV's community-centric approach and Konovo's platform scale creates new opportunities for researchers to engage patient and caregiver audiences more effectively."

Business Wire
Feb 3rd, 2026
Konovo acquires Rare Patient Voice to connect 200,000 patients with healthcare research

Konovo, a healthcare intelligence company, has acquired Rare Patient Voice (RPV), a patient recruitment firm with over 200,000 registered patients and family caregivers across rare, chronic and complex conditions. The acquisition combines RPV's patient relationships with Konovo's technology platform and healthcare provider access. Founded in 2013, RPV operates across nine countries and covers more than 1,500 diseases. The deal enables researchers to access hard-to-reach patient populations whilst integrating patient and physician insights through a single platform. Konovo will use its infrastructure to expand RPV's reach whilst maintaining its community-focused approach. The company aims to accelerate high-quality insights from patients and healthcare professionals, particularly in rare and complex conditions where traditional recruitment methods often struggle.

MrWeb Ltd
Jan 6th, 2026
Daily Research News Online

Daily research news online. The global MR industry's daily paper since 2000. Senior hires strengthen global offer for Konovo. In Watertown, MA, USA, healthcare intelligence company Konovo has appointed two healthcare technology industry veterans, Swathi Kulkarni and Tom Halliday to its executive leadership team, with the respective titles of MD India and Chief Commercial Officer (CCO). Konovo was formed nine months ago from the merger of the three healthcare research firms within Apollo Intelligence - InCrowd, SHG and GlocalMind. The group operates across thirteen countries in the Americas, Europe and Asia, and is a portfolio company of Frazier Healthcare Partners. The company combines a global panel of healthcare professionals and patients with mobile-first quant and qual research capabilities, plus AI-based capabilities to streamline and integrate the gathering and sharing of insights. Last year the company added clinical research data veteran Gadi Lachman and former Kantar Health exec Jeremy Brody to its Board, and recently it launched a new suite called Survey Studio, allowing clients to rapidly design and script 'therapeutic-specific' healthcare surveys. Konovo says the two new hires will accelerate the expansion of its AI-native intelligent technology platform to meet the needs of all geographies. Kulkarni (pictured above) brings more than twenty years of experience building pioneering health tech companies and scaling them globally, most recently as CEO and co-founder of Elda Health, a full-stack digital wellness platform; and as Head of Health Management at Aditya Birla Health Insurance. Earlier she held executive leadership roles at Nua, a personal care product manufacturer; Inksedge, an events and communications company; and Komli Media, India's leading digital marketing platform. In her new role she will lead Konovo's India Innovation Hub, including strategy, P&L, growth delivery, talent and culture, and work to maximize the role that India plays in Konovo's success. Halliday (pictured below) also brings more than two decades of experience to bear on his new role, from life sciences roles on both the client and agency sides. Most recently, he was Strategic Intelligence General Manager at pharmaceutical solutions group Norstella, leading development of and strategy for the Strategic Intelligence business unit. Earlier he was CCO and Head of Real-World Data (RWD) at Clarivate Life Sciences, and held various leadership positions in Strategic Analytics and Competitive Intelligence at pharma and diagnostics giant Roche. In his new CCO role he will work to strengthen Konovo's senior-level partnerships and expand relationships across the global MR ecosystem. CEO Tal Rosenberg comments: 'Swathi and Tom are proven transformation agents whose deep life science technology expertise and relationships will help us introduce innovations to address longstanding market research industry challenges. With their strategic skills on our leadership team, Konovo can accelerate the expansion of our intelligent platform and help more healthcare and life science organizations worldwide to gain faster, more actionable insights that deliver value throughout their operations.' The company is on the web at www.konovo.com.

Market Research Society (MRS)
Nov 12th, 2025
Konovo launches AI healthcare survey tool

Konovo launches AI healthcare survey tool. US - Healthcare insight company Konovo has added a self-service platform for designing and scripting healthcare surveys. Konovo has formed a healthcare and life sciences partnership with AI market research platform Metaforms to integrate the latter's programming AI technology for the 'Survey Studio' tool. Through the tool, healthcare researchers can conduct surveys based on Konovo's life sciences insight base - around 15 years of healthcare research data, design standards and methodology. Advertisement The tool uses AI agents to bring together questionnaire design and survey programming. Konovo was formed in 2025 from the merger of healthcare research businesses InCrowd, SHG, and GlocalMind by owner Apollo Intelligence. The new survey tool will be available from the company in the fourth quarter of 2025. Tal Rosenberg, chief executive, Konovo, said: "We developed Survey Studio to give healthcare researchers an AI tool trained on healthcare intelligence, which can understand their context, governance requirements, and research needs, and help them build a field-ready survey in real time.

Recently Posted Jobs

Sign up to get curated job recommendations

Konovo is Hiring for 15 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →